IL109587A - Heparin fractions obtained by nitrous depolymerization, with low nitroso-compound content, method for obtaining them and pharmaceutical compositions containing them - Google Patents

Heparin fractions obtained by nitrous depolymerization, with low nitroso-compound content, method for obtaining them and pharmaceutical compositions containing them

Info

Publication number
IL109587A
IL109587A IL109587A IL10958794A IL109587A IL 109587 A IL109587 A IL 109587A IL 109587 A IL109587 A IL 109587A IL 10958794 A IL10958794 A IL 10958794A IL 109587 A IL109587 A IL 109587A
Authority
IL
Israel
Prior art keywords
nitroso
obtaining
low
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL109587A
Other languages
English (en)
Other versions
IL109587A0 (en
Original Assignee
Choay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9446915&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL109587(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Choay Sa filed Critical Choay Sa
Publication of IL109587A0 publication Critical patent/IL109587A0/xx
Publication of IL109587A publication Critical patent/IL109587A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL109587A 1993-05-07 1994-05-06 Heparin fractions obtained by nitrous depolymerization, with low nitroso-compound content, method for obtaining them and pharmaceutical compositions containing them IL109587A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9305534A FR2704861B1 (fr) 1993-05-07 1993-05-07 Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.

Publications (2)

Publication Number Publication Date
IL109587A0 IL109587A0 (en) 1994-08-26
IL109587A true IL109587A (en) 1997-04-15

Family

ID=9446915

Family Applications (1)

Application Number Title Priority Date Filing Date
IL109587A IL109587A (en) 1993-05-07 1994-05-06 Heparin fractions obtained by nitrous depolymerization, with low nitroso-compound content, method for obtaining them and pharmaceutical compositions containing them

Country Status (26)

Country Link
US (1) US5599801A (ja)
EP (1) EP0623629B1 (ja)
JP (1) JP3529835B2 (ja)
KR (1) KR100328095B1 (ja)
CN (1) CN1066155C (ja)
AT (1) ATE141618T1 (ja)
AU (1) AU672291B2 (ja)
BR (1) BR9401920A (ja)
CA (1) CA2122930C (ja)
CZ (1) CZ287889B6 (ja)
DE (1) DE69400385T2 (ja)
DK (1) DK0623629T3 (ja)
ES (1) ES2093494T3 (ja)
FI (1) FI107388B (ja)
FR (1) FR2704861B1 (ja)
GR (1) GR3021648T3 (ja)
HK (1) HK1007432A1 (ja)
HU (1) HU221595B (ja)
IL (1) IL109587A (ja)
MY (1) MY110862A (ja)
NO (1) NO306952B1 (ja)
NZ (1) NZ260460A (ja)
PL (1) PL178294B1 (ja)
RU (1) RU2133253C1 (ja)
TW (1) TW438812B (ja)
ZA (1) ZA943152B (ja)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5980865A (en) * 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
US6217863B1 (en) 1995-10-30 2001-04-17 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase I
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
WO2000012726A2 (en) * 1998-08-27 2000-03-09 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase i and ii
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
CA2643162C (en) * 1999-04-23 2018-01-02 Massachusetts Institute Of Technology Polymer identification, compositional analysis and sequencing, based on property comparison
CA2402160C (en) * 2000-03-08 2012-02-14 Massachusetts Institute Of Technology Heparinase iii and uses thereof
US8227449B2 (en) * 2000-03-30 2012-07-24 Glycores 2000 S.R.L. Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
IT1318432B1 (it) * 2000-03-30 2003-08-25 Inalco Spa Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro
JP4911865B2 (ja) * 2000-09-12 2012-04-04 マサチューセッツ インスティテュート オブ テクノロジー 低分子量ヘパリンに関連する方法および生成物
AU2002224408B2 (en) * 2000-10-18 2007-08-23 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
US20050027117A1 (en) * 2000-12-18 2005-02-03 Pasqua Oreste Anticoagulant and antithrombotic LMW-glycosaminoglycans derived from K5 polysaccharide and process for their preparation
JP2002293804A (ja) * 2001-03-28 2002-10-09 Itoham Foods Inc 低分子量ヘパリンの製造法
WO2003078960A2 (en) * 2002-03-11 2003-09-25 Momenta Pharmaceuticals, Inc. Analysis of sulfated polysaccharides
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
ITMO20040199A1 (it) * 2004-07-29 2004-10-29 Biofer Spa Procedimento per la purificazione da gruppi e n no rsidui di eparine a basso peso molecolare ottentite tramite nitrosazione.
JP2006291028A (ja) * 2005-04-11 2006-10-26 Q P Corp 低分子ヘパリンまたはその塩、ならびにその製造方法
ATE552004T1 (de) 2005-11-30 2012-04-15 Istituto G Ronzoni Oral verabreichbare heparinderivate
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
EP2526122B1 (en) * 2010-01-19 2020-06-10 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
AU2011303081B2 (en) * 2010-09-14 2015-08-13 Fuso Pharmaceutical Industries, Ltd. High purity heparin and production method therefor
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN102633905B (zh) * 2011-04-11 2014-10-08 南通天龙畜产品有限公司 一种肝素钠中不被亚硝酸降解且在肝素钠保留时间附近出峰的物质的去除方法
CN104045744B (zh) * 2014-06-26 2016-01-06 常州千红生化制药股份有限公司 达肝素钠的制备方法
CN104098716B (zh) * 2014-07-16 2015-04-22 南京健友生化制药股份有限公司 一种达肝素钠精品的生产方法
US10688249B2 (en) * 2015-06-11 2020-06-23 Virchow Biotech Pvt. Ltd. Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
CN105294885A (zh) * 2015-11-23 2016-02-03 山东大学 一种新来源亚硝酸降解低分子肝素的制备方法
CN111727204B (zh) * 2018-02-14 2023-01-31 生物E有限公司 用于制备达肝素钠的改进方法
RU186728U1 (ru) * 2018-10-19 2019-01-30 Федеральное государственное бюджетное образовательное учреждение высшего образования "МИРЭА - Российский технологический университет" Лабораторное устройство для отмывки порошковых продуктов химических реакций от посторонних примесей
EP3997238A1 (en) 2019-07-09 2022-05-18 Optimvia, LLC Methods for synthesizing anticoagulant polysaccharides
CN110845641A (zh) * 2019-11-07 2020-02-28 中国药科大学 一种肝素寡糖及其在制备抗血管生成药物中的应用
CN110787489A (zh) * 2019-11-20 2020-02-14 江苏千牧生物科技股份有限公司 一种肝素钠加工使用的分离装置及加工的工艺
EP4182452A1 (en) 2020-07-14 2023-05-24 Optimvia, LLC Methods for synthesizing non-anticoagulant heparan sulfate
CN115304688A (zh) * 2022-08-25 2022-11-08 湖北亿诺瑞生物制药有限公司 一种达肝素钠的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
US4351938A (en) * 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
US4438261A (en) * 1980-05-19 1984-03-20 Riker Laboratories, Inc. Anticoagulant substance
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
FR2503714B1 (fr) * 1981-04-10 1986-11-21 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
US5094815A (en) * 1988-05-18 1992-03-10 Cornell Research Foundation, Inc. Photolytic interface for HPLC-chemiluminescence detection of non volatile N-nitroso compounds
US5032679A (en) * 1988-12-15 1991-07-16 Glycomed, Inc. Heparin fragments as inhibitors of smooth muscle cell proliferation
IT1243300B (it) * 1990-12-20 1994-05-26 Fidia Spa Derivati dell'eparina
US5385937A (en) * 1991-04-10 1995-01-31 Brigham & Women's Hospital Nitrosation of homocysteine as a method for treating homocysteinemia

Also Published As

Publication number Publication date
NO941686L (no) 1994-11-08
NO306952B1 (no) 2000-01-17
DE69400385D1 (de) 1996-09-26
CA2122930C (en) 2000-10-24
CN1066155C (zh) 2001-05-23
MY110862A (en) 1999-05-31
GR3021648T3 (en) 1997-02-28
AU672291B2 (en) 1996-09-26
AU6191294A (en) 1994-11-10
DE69400385T2 (de) 1996-12-19
TW438812B (en) 2001-06-07
HK1007432A1 (en) 1999-04-09
ATE141618T1 (de) 1996-09-15
ES2093494T3 (es) 1996-12-16
JPH07126302A (ja) 1995-05-16
CN1096034A (zh) 1994-12-07
FI942095A0 (fi) 1994-05-06
CZ113294A3 (en) 1994-12-15
HU9401446D0 (en) 1994-08-29
CZ287889B6 (cs) 2001-03-14
EP0623629A1 (fr) 1994-11-09
JP3529835B2 (ja) 2004-05-24
EP0623629B1 (fr) 1996-08-21
ZA943152B (en) 1995-01-09
DK0623629T3 (da) 1996-12-23
BR9401920A (pt) 1994-11-29
US5599801A (en) 1997-02-04
RU94015595A (ru) 1996-09-27
HUT70553A (en) 1995-10-30
HU221595B (hu) 2002-11-28
FR2704861A1 (fr) 1994-11-10
CA2122930A1 (en) 1994-11-08
KR100328095B1 (ko) 2002-06-20
FR2704861B1 (fr) 1995-07-28
RU2133253C1 (ru) 1999-07-20
FI107388B (fi) 2001-07-31
NZ260460A (en) 1996-02-27
FI942095A (fi) 1994-11-08
NO941686D0 (no) 1994-05-06
IL109587A0 (en) 1994-08-26
PL178294B1 (pl) 2000-04-28

Similar Documents

Publication Publication Date Title
IL109587A (en) Heparin fractions obtained by nitrous depolymerization, with low nitroso-compound content, method for obtaining them and pharmaceutical compositions containing them
AU2630395A (en) Rheumatoid arthritis remedy containing IL-6 antagonist as effective component
AU2610799A (en) Glp-1 derivatives with helix-content exceeding 25 per cent, forming partially structured micellar-like aggregates
AU5612694A (en) Injectable composition
UA39174C2 (uk) Асоціати депротонованої гіалуронової кислоти, спосіб одержання асоціатів депротонованої гіалуронової кислоти, фармацевтична композиція та спосіб одержання фармацевтичної композиції
PT91553A (pt) Processo de preparacao de uma composicao contendo morfina
AU7177794A (en) Absorption enhancers for drug administration
WO1996011949A3 (en) Analogs of keratinocyte growth factor
HUT61554A (en) Process for producing 2,8-dioxabicyclo/3.2.1/octane derivatives and pharmaceutical compositions comprising same
UA39101C2 (uk) ПОХІДНІ 11<font face="Symbol">b</font>-БЕНЗАЛЬДОКСИМ-ЕСТРА-4,9-ДІЄНУ, СПОСІБ ЇХ ОДЕРЖАННЯ І ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З АНТИПРОГЕСТИНОВОЮ АКТИВНІСТЮ
HU9301990D0 (en) Method for producing inclusion compounds of 5,10-methylene-tetrahydro-folic acid with cyclodextrin
HU9402292D0 (en) New baccatine-iii and 10-deacetyl-baccatine-iii derivatives, process for producing them and pharmaceutical compositions containing them as active component
AU648890B2 (en) Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent, central nervous system stimulant or sigma receptor agonist
HU9401914D0 (en) Piperidine- and piperazine derivatives, pharmaceutical compositions containing them as active components and process for producing both
HUT71349A (en) Heteroaryl-piperidine derivatives, process for producing them and pharmaceutical compositions containing them
AU576914B2 (en) 5-cyanopyridine-2-diazohydroxide, basic salts thereof
EA199600048A3 (ru) N,n-диэтил-8,8-дипропил-2-азаспиро[4,5]декан-2-пропанамин дималеат, фармацевтическая композиция на его основе и способ индуцирования иммуномодуляции
ES2134128A1 (es) Un procedimiento de reduccion de los niveles residuales de disolventes, presentes en las composiciones farmaceuticas, en particular en los antibioticos y antibioticos obtenidos segun el mismo.
HU9401191D0 (en) 2-aminio-4-heteroaryl-1,4-dihidropyridines, process for producing them and pharmaceutical compositions containing them as active component
HUT53649A (en) Process for producing (d)-2,3-dihydro-2',5'-dioxo-6-fluoro-spiro(4h-1-benzopyran-4,4'-imidazolidine)-2-carboxamide derivatives and pharmaceutical compositions comprising such compounds
PT89500A (pt) Processo para a preparacao de derivados de tetra-hidropiridina e de composicoes farmaceuticas que os contem
HUT70043A (en) Quinolonecarboxylic derivatives and process for producing them, and celladhesion-inhibiting pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired